Department of Biomedical Engineering, Columbia University, New York, NY, USA.
Lab Chip. 2012 Jun 21;12(12):2118-34. doi: 10.1039/c2lc21204h. Epub 2012 Feb 17.
A large part of the excitement behind microfluidics is in its potential for producing practical devices, but surprisingly few lab-on-a-chip based technologies have been successfully introduced into the market. Here, we review current work in commercializing microfluidic technologies, with a focus on point-of-care diagnostics applications. We will also identify challenges to commercialization, including lessons drawn from our experience in Claros Diagnostics. Moving forward, we discuss the need to strike a balance between achieving real-world impact with integrated devices versus design of novel single microfluidic components.
微流控技术的一大吸引力在于其具有生产实用设备的潜力，但令人惊讶的是，只有极少数基于芯片的实验室技术成功推向市场。在这里，我们回顾了微流控技术商业化的现有工作，重点关注即时诊断应用。我们还将确定商业化的挑战，包括我们在 Claros Diagnostics 获得的经验教训。展望未来，我们讨论了需要在实现具有集成设备的现实影响与设计新颖的单个微流控组件之间取得平衡。
